The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Abstract
We conducted a prospective, nested, case-control study of inflammatory markers as predictors of type 2 diabetes among 32,826 women who provided blood samples in 1989 through 1990 in the Nurses’ Health Study. Among women free of diabetes, cardiovascular disease, or cancer at baseline, 737 had developed diabetes by 2000. Control women (n = 785) were selected matched on age, fasting status, race, and BMI for cases in the top BMI decile. Baseline levels of tumor necrosis factor (TNF)-α receptor 2, interleukin (IL)-6, and C-reactive protein (CRP) were significantly higher among case than control subjects (all P ≤ 0.001). After adjusting for BMI and other lifestyle factors, all three biomarkers significantly predicted diabetes risk; the odds ratios (ORs) comparing extreme quintiles were 1.64 (95% CI 1.10–2.45) for TNF-αR2, 1.91 (1.27–2.86) for IL-6, and 4.36 (2.80–6.80) for CRP (P for trend <0.001 for all biomarkers). In a multivariate model simultaneously including the three biomarkers, only CRP levels were significantly associated with risk of diabetes (OR comparing extreme quintiles of CRP = 3.99, P for trend <0.001). These data support the role of inflammation in the pathogenesis of type 2 diabetes. Elevated CRP levels are a strong independent predictor of type 2 diabetes and may mediate associations of TNF-αR2 and IL-6 with type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, this syndrome has been noted to be associated with a state of chronic, low-grade inflammation.47,48”
From Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (2005) · cites this paper as [47]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Lifestyle interventions such as exercise and weight loss are effective in lowering CRP and other inflammatory markers (43,44) and in preventing type 2 diabetes in subjects with impaired glucose tolerance (45,46).”
BackgroundReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Research works printed but not linked: 1
- SAS Institute Inc: SAS/STAT User’s Guide. V. 6, 4th ed., vol. 1. Cary, NC, SAS Institute Inc.,1989
Cited by
Sorted by citations
Items 501–600 of 787
Obesity and diabetes: dual epidemics on the rise
Wang, J., Armour, T., Geiss, L. S., & Engelgau, M. M. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000157075.71572.c3 · Cited by 12
Patil, R., Rooge, S. B., Damame, H. H., Haldavnekar, V., & Arvindekar, A. U. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100829 · Cited by 11
The risk factors of type 2 diabetes in hypertensive subjects
Chen, Y., Ma, J., Lu, D., & Fang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.901614 · Cited by 14
Bakhshimoghaddam, F., Jafarirad, S., Maraghi, E., & Ghorat, F. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114523001903 · Cited by 11
Sun, H., Yang, J., Ma, L., & Wu, Y. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02004-0 · Cited by 14
Diabetes and metabolic dysfunction in COPD
Archer, J. R. H., & Baker, E. H. (2009) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2009.10.001 · Cited by 11
Role of nutrition in preventing insulin resistance in children
Blasetti, A., Franchini, S., Comegna, L., Prezioso, G., & Chiarelli, F. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0189 · Cited by 11
Nkinda, L., Patel, K. T., Njuguna, B., Ngangali, J. P., Memiah, P. T. N., Bwire, G. M., Majigo, M. V., Mizinduko, M. M., Pastakia, S. D., & Lyamuya, E. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0407-y · Cited by 11
Koia, J. H., & Shepherd, P. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00935 · Cited by 15
Kang, J. H., Wiggs, J. L., & Pasquale, L. R. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11191 · Cited by 11
E‐Selectin Genotypes and Risk of Type 2 Diabetes in Women
Meigs, J. B., Hu, F. B., Perhanidis, J. A., Hunter, D., Rifai, N., & Manson, J. E. (2005) · Obesity Research · doi:10.1038/oby.2005.54 · Cited by 11
Self-citationMetabolic Consequences of Obesity
Hu, F. B. (2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195312911.003.0008 · Cited by 11
Self-citationDietary Mg Intake and Biomarkers of Inflammation and Endothelial Dysfunction
Liu, S., & Chacko, S. A. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-044-1_2 · Cited by 11
Tobacco smoke, systemic inflammation and the risk of type 2 diabetes
Mascitelli, L., & Pezzetta, F. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01614.x · Cited by 11
Reddy, V. K. K., Shiddapur, G. S., Jagdale, N., Kondapalli, M. P., & Adapa, S. (2024) · Cureus · doi:10.7759/cureus.67014 · Cited by 14
Metabolic Syndrome, Obesity Paradox and Testosterone Level
Emanuele, V. (2015) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000172 · Cited by 10
Oda, E. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0788-y · Cited by 10
Utku, İ. K., Okuturlar, Y., Demir, E. Y., Harmankaya, Ö., Açıksarı, G., Uygun, T., Kural, A., Ozkan, H., Mert, M., & Kumbasar, A. (2015) · PubMed Central · Cited by 10
Risk Markers for Atherothrombotic Disease
Ridker, P. M., & Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00044-5 · Cited by 10
C‐reactive protein and incident diabetes in patients with arterial disease
Verhagen, S. N., Wassink, A. M. J., van der Graaf, Y., Visseren, F. L. J., & SMART Study Group (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12142 · Cited by 10
Kaya, T., Akçay, E. Ü., Ertürk, Z., Ergenç, H., & Tamer, A. (2018) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1712-28 · Cited by 10
Chen, Y., Fang, W., Wang, C., Kao, T., Chang, Y., Yang, H., Wu, C., Sun, Y., & Chen, W. (2019) · Scientific Reports · doi:10.1038/s41598-019-50606-1 · Cited by 10
Noushin, T., Hossain, N. I., Tahrin, R., Islam, M. N., & Tabassum, S. (2025) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2025.100772 · Cited by 10
Mini-revisión: Inflamación crónica y estrés oxidativo en la diabetes mellitus
Rosado-Pérez, J., & Mendoza-Núñez, V. M. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 9
Sun, H., Yan, Y., Xu, C., Wan, H., & Liu, D. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b06170 · Cited by 9
Kataria, I., Chadha, R., & Pathak, R. (2013) · Reviews in Health Care · doi:10.7175/rhc.v4i4.667 · Cited by 11
Genetic Susceptibility to Type 2 Diabetes and Implications for Therapy
Zia, A. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000248 · Cited by 9
Hsu, T., Lee, C., Lin, F.-Y., Wasser, S. P., & Lo, H. (2014) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.124347 · Cited by 9
Conroy, S. M., Neilson, H. K., O’Reilly, R., Woolcott, C. G., Stanczyk, F. Z., Courneya, K. S., & Friedenreich, C. M. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000883 · Cited by 8
Characteristics of factors for decreased lung function in elderly patients with type 2 diabetes
Ishii, M., Yamaguchi, Y., Hamaya, H., Ogawa, S., Imura, M., & Akishita, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-56759-3 · Cited by 9
Begolli-Stavileci, G., Begolli, G., & Begolli, L. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.3199 · Cited by 8
Chikoti, S., Mahwish, U. N., Sumanlatha, G., & Jahan, P. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108304 · Cited by 8
The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy
Wyne, K. L. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00522.x · Cited by 8
Martínez‐Abundis, E., González-Ortı́z, M., Mercado-Sesma, A. R., Drateln, C. R.-V., & Moreno-Andrade, A. (2013) · Obesity Facts · doi:10.1159/000355720 · Cited by 8
Metabolic syndrome and diabetes for the urologist
Fleshner, N. E., & Bhindi, B. (2014) · Canadian Urological Association Journal · doi:10.5489/cuaj.2314 · Cited by 8
Eliades, M., & Pittas, A. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-303-9_49 · Cited by 8
Relationship between subclinical inflammation, obesity, diabetes and related disorders
Tataranni, P. A. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.08.014 · Cited by 8
Cardiometabolic Syndrome and Vascular Calcification
Chen, W., & Chen, Y. (2022) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2022.2.e2 · Cited by 9
COMPLICATIONS OF PREGNANCY IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Azizia, M., & Hardiman, P. J. (2011) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539511000088 · Cited by 7
Discovery of subtle effects in a human intervention trial through multilevel modeling
Rubingh, C. M., van Erk, M. J., Wopereis, S., van Vliet, T., Verheij, E. R., Cnubben, N. H. P., van Ommen, B., van der Greef, J., Hendriks, H., & Smilde, A. K. (2010) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2010.06.003 · Cited by 7
Thibault, V., Morisset, A., Brown, C., Carpentier, A. C., Baillargeon, J., Langlois, M., & Gagnon, C. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515001610 · Cited by 7
Al‐Rawaf, H. A., Alghadir, A. H., & Gabr, S. A. (2021) · BioMed Research International · doi:10.1155/2021/7453000 · Cited by 7
Pouresmaeil, V., Mashayekhi, S., & Yazdi, M. S. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00956-3 · Cited by 7
Lan, C.-C. E., Ko, Y., Yu, H., Li, W.-C., Wu, C., Lu, Y., Yang, Y., & Chen, G. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.08.004 · Cited by 7
Wu, J., Liang, Z., Zhou, J., Zhong, C., Jiang, W., Zhang, Y., & Zhang, S. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.04.011 · Cited by 8
Epidemiology and Risk Factors of Type 2 Diabetes
Ley, S. H., & Meigs, J. B. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_5-1 · Cited by 7
Self-citationSchmidt, L., Nelson, H. H., Thyagarajan, B., Hunter‐Schlichting, D., Pankow, J. S., Capistrant, B. D., & Prizment, A. E. (2018) · Diabetic Medicine · doi:10.1111/dme.13781 · Cited by 7
Increased risk of new-onset type 2 diabetes in people with chronic kidney disease
Wang, I., Tsai, T., Hung, Y., Wang, T.-Y., Yen, T., Lin, C., & Sung, F. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02075-8 · Cited by 7
Mańkowska‐Cyl, A., Pollak, J., & Sypniewska, G. (2006) · Europe PMC (PubMed Central) · Cited by 7
Xu, F., Wang, N., Li, G., Tian, D., & Shi, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s330700 · Cited by 7
Comasco, E., Iliadis, S. I., Larsson, A. O., Olovsson, M., Oreland, L., Poromaa, I. S., & Skalkidou, A. (2013) · Obesity · doi:10.1002/oby.20349 · Cited by 7
Percutaneous coronary intervention increases leptin and decreases adiponectin levels
Azar, R. R., Sarkis, A., Salameh, E., Gannagé‐Yared, M., Amm‐Azar, M., Badaoui, G., Germanos, M., & Kassab, R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02654.x · Cited by 7
Associations between common contraceptive use and circulating inflammatory biomarkers
Mongiovi, J. M., Babic, A., Sasamoto, N., Shafrir, A. L., Huang, T., Townsend, M. K., Peres, L. C., Tworoger, S. S., & Terry, K. L. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae135 · Cited by 7
Genetic Modification of the Effects of Alcohol on Metabolic and Clinical Phenotypes: A Review
Kiage, J. N., James, L. O., & Kabagambe, E. K. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0086-2 · Cited by 6
Zhao, J., Cao, X., Li, Q., Xie, J., & Wu, H. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04405-z · Cited by 6
Hyperglycemia, Lung Infection, and Inflammation
Baker, E. H., Archer, J. R. H., & Srivastava, S. A. (2009) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e3181b5d1df · Cited by 6
Przewlekła Obturacyjna Choroba Płuc i Choroby Sercowo-Naczyniowe—“Kontinuum Sercowo-PłUcne”
Batura‐Gabryel, H., & Grabicki, M. (2014) · Advances in respiratory medicine · doi:10.5603/piap.2014.0078 · Cited by 6
MATERNAL SERUM C- REACTIVE PROTEIN CONCENTRATION IN GESTATIONAL DIABETES
Mojibian, M., Soheilykhah, S., Rahimi‐Saghand, S., Rashidi, M., & Saeedeh, S. (2011) · Cited by 6
Moustafa, S. R. (2015) · AFMN Biomedicine · doi:10.1515/afmnai-2016-0020 · Cited by 6
Dhas, Y., Banerjee, J., Damle, G., & Mishra, N. (2019) · Steroids · doi:10.1016/j.steroids.2019.108532 · Cited by 6
Uchio, R., Okuda-Hanafusa, C., Saji, R., Kawasaki, K., Muroyama, K., Murosaki, S., Yamamoto, Y., & Hirose, Y. (2022) · Nutrients · doi:10.3390/nu14183763 · Cited by 6
Kharb, S., Goel, K., & Rajput, R. (2019) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_85_19 · Cited by 6
Stem Cells Targeting Inflammation as Potential Anti-aging Strategies and Therapies
Gonzalez, Woynarowski, D., & Geffner, L. (2015) · Cell & Tissue Transplantation & Therapy · doi:10.4137/cttt.s19477 · Cited by 6
Ware, W. R. (2010) · Cited by 6
Cellular, Molecular and Therapeutic Advances in Type 2 Diabetes Mellitus
Potdar, P. D., & Chaudhari, M. B. (2016) · Diabetes Management · Cited by 4
Oda, E. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1998 · Cited by 5
Kp, Z., Попова, В. В., Orlenko, V. L., Furmanova, O. V., & Tronko, M. D. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.7.2021.244969 · Cited by 5
Hypovitaminosis D in patients with type 2 diabetes
Stieben, L. A. R., Dobry, R., Anca, L., González, A., López, M. I., Bayo, S., Sánchez, A., & Brance, M. L. (2022) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v79.n3.35158 · Cited by 5
Takahashi, F., Hashimoto, Y., Okada, H., Kondo, Y., Kaji, A., Sakai, R., Kawate, Y., Okamura, T., Nakanishi, N., Majima, S., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01331-4 · Cited by 5
Algur, Y., Rummo, P. E., McAlexander, T. P., Silva, S. D., Lovasi, G. S., Judd, S. E., Ryan, V., Malla, G., Koyama, A. K., Lee, D. C., et al. (2023) · International Journal of Health Geographics · doi:10.1186/s12942-023-00345-4 · Cited by 5
Watkins, S. M., Rowe, M. W., Kolberg, J. A., Wagenknecht, L. E., & Bergman, R. N. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03625.x · Cited by 5
Nadeem, A., Naveed, A. K., Hussain, M. M., Aslam, M. N., Siddiqui, A., & Saeed, S. A. (2013) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0147-x · Cited by 5
Relation Between C-Reactive Protein and Impaired Fasting Glucose in Obese Subjects
Simental‐Mendía, L. E., Lazalde, B., Zambrano-Galván, G., Simental‐Saucedo, L., Rábago-Sánchez, E., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2012) · Inflammation · doi:10.1007/s10753-012-9492-z · Cited by 5
Plasma NOx Concentrations in Glucose Intolerance and Type 2 Diabetes
Binh, P. N. T., Abe, Y., Tien, P. G., Son, L. N. T. D., Hanh, T. T. M., Diep, D. T. N., Qui, L. T. K., Kawano, M., & Maruyama, C. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7393 · Cited by 5
TM, V. J. R. (2014) · Journal of Nutritional Disorders & Therapy · doi:10.4172/2161-0509.1000145 · Cited by 5
Asgary, S., Rafieian-Kopaei, M., & Goli‐malekabadi, N. (2016) · journal of ilam university of medical sciences · doi:10.18869/acadpub.sjimu.24.5.55 · Cited by 5
Deployment Length, Inflammatory Markers, and Ambulatory Blood Pressure in Military Couples
Holliday, S. B., DeSantis, A. S., Germain, A., Buysse, D. J., Matthews, K. A., & Troxel, W. (2017) · Military Medicine · doi:10.7205/milmed-d-16-00327 · Cited by 5
Association of Neurogranin with Delirium Among Critically Ill Patients
Wanderlind, M. L., Gonçalves, R. C., Tomasi, C. D., Dal‐Pizzol, F., & Ritter, C. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0328 · Cited by 5
Ehteram, H., Raji, S., Rahmati, M., Teymoori, H., Safarpour, S., Poursharifi, N., Zadeh, M. H., Pakzad, R., Habibi, H., & Mobarra, N. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.400 · Cited by 5
Joo, J.-H., Lee, J.-G., Kim, S.-W., Lee, J.-H., Lee, J., & Lee, K.-J. (2020) · Annals of Occupational and Environmental Medicine · doi:10.35371/aoem.2020.32.e29 · Cited by 7
Metabolic Syndrome and Inflammation
Pop‐Busui, R., & Pietropaolo, M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_5 · Cited by 5
A Personalized Approach to Metabolic Aspects of Obesity
Brietzke, S. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20206 · Cited by 5
Nath, R. (2016) · Diabetes & Metabolic Disorders · doi:10.24966/dmd-201x/100012 · Cited by 5
Potential for Improving Health: Calcium Bioavailability in Milk and Dairy Products
Ibeagha-Awemu, E. M., Kgwatalala, P. M., & Zhao, X. (2009) · doi:10.1002/9780813821504.ch16 · Cited by 5
Serum cystatin C and mild cognitive impairment: The mediating role of glucose homeostasis
Li, K., Xu, J., Zhao, M., Wu, J., Mei, Y., Zhou, Q., Zhao, J., Li, Y., Yang, M., & Xu, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1102762 · Cited by 4
Beasley, J. M., Wedick, N. M., Rajpathak, S. N., Xue, X., Holmes, M. D., Gunter, M. J., Wylie‐Rosett, J., Rohan, T. E., Pollak, M., Kaplan, R. C., et al. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.04.006 · Cited by 4
Self-citationZhou, J., Sheng, J., Fan, Y., Zhu, X., & Wang, S. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1515184 · Cited by 8
IL-1β and IL-1Ra Variant Profiles in Turkish Patients with Diabetic Peripheral Neuropathy
Nursal, A. F., İnanır, A., Rüstemoğlu, A., Kaya, S. U., Şahin, K., & Yığıt, S. (2018) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666181022165048 · Cited by 4
Hernández-Ledesma, A. L., Rodríguez-Méndez, A. J., Gallardo-Vidal, L. S., Robles‐Osorio, L., Villagrán-Herrera, M. E., Martínez-Peña, M. G., & García-Gasca, T. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103265 · Cited by 5
Epidemiology and Risk Factors of Type 2 Diabetes
Ley, S. H., & Meigs, J. B. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_5 · Cited by 7
Self-citationSi, X., Si, Y., Zhang, S., Liu, Y., Liu, Y., Wang, H., & Wang, Z. (2023) · Cogent Food & Agriculture · doi:10.1080/23311932.2023.2242641 · Cited by 4
Endothelial Dysfunction and Metabolic Syndrome
Lee, S. K., Khambhati, J., Bhargava, A., Engels, M. C., Sandesara, P. B., & Quyyumi, A. A. (2017) · Hypertension Journal · doi:10.5005/jp-journals-10043-0075 · Cited by 4
Badawi, A. F., Cuda, Garcia-Bailo, Karmali, M. A., & El‐Sohemy, A. (2012) · Journal of Inflammation Research · doi:10.2147/jir.s27911 · Cited by 4
Quantitative Analysis of Cytokines in Diabetic Nephropathy
Gedela, S., Guruju, V. P. B., Sulakshana, M., Maheswari, I. L., Prabhakar, T., GirijaSankar, Rao, A. A., & Sridhar, G. R. (2009) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000079 · Cited by 4
THE ROLE OF THE PANCREATIC AMYLOID IN THE PATHOGENESIS OF TYPE 2 DIABETES
Ionescu-Tirgoviste, C., Guja, C., Vasilica, C., & Gutu, D. (2010) · Cited by 4
Biswas, S. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000429 · Cited by 4
Psoriasis ve metabolik sendrom
Günaydın, A., Aytimur, D., & Özdemir, F. (2014) · TURKDERM · doi:10.4274/turkderm.57767 · Cited by 4
Inflammation and Incident Diabetes: The Role of Race and Ethnicity
Yu, M. G., & King, G. L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac132 · Cited by 4
Gupta, R., Shivashankar, R., Kondal, D., Gokulakrishnan, K., Patel, S. A., Ali, M. K., Narayan, K. M. V., Mohan, V., Tandon, N., & Prabhakaran, D. (2024) · Acta Diabetologica · doi:10.1007/s00592-023-02229-2 · Cited by 4
Metadata
- Authors
- Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2004-03-01
- Volume
- 53
- Issue
- 3
- Pages
- 693-700
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2153214557
- Cited by
- 788
- References
- 51
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 20 · 2023: 22 · 2022: 33 · 2021: 32 · 2020: 25 · 2019: 34 · 2018: 41 · 2017: 48 · 2016: 39 · 2015: 42 · 2014: 55 · 2013: 42 · 2012: 57
- FWCI
- 25.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (CA-87969, P01CA087969)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845, DK58845)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- type 2 diabetes, inflammatory markers, C-reactive protein, interleukin-6, inflammation, diabetes risk prediction, women, Nurses' Health Study, body mass index
- MeSH terms
- Adult, Body Constitution, C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Insulin, Menopause, Middle Aged, Risk Factors, Smoking, United States, Cohort Studies, Biomarkers, Antigens, CD, Interleukin-6, Body Mass Index, Receptors, Tumor Necrosis Factor, Receptors, Tumor Necrosis Factor, Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review